Sharemaestro company-news research for ADMA Biologics Inc (ADMA), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
NASDAQ
United States
Measured evidence
Company news sentiment
ADMA news sentiment
ADMA Biologics Inc
Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.
Weighted tone54Neutral is 50
Balanced news tone
50/100 evidence confidence
100% direct company focus
2 current stories across 2 publishers
Current company news
Price moving ahead of tone
Balanced news tone is drawn from 2 fresh independent stories, including 2 company-specific items across 2 publishers.
Latest source headline ADMA DEADLINE TOMORROW: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA globenewswire.com · 09 Aug 2026 15:41What supports the read
2 current stories are mapped specifically to ADMA.
Cross-story agreement is 94/100, indicating a comparatively coherent tape.
What tempers the read
Only 2 publishers currently contribute to the measured read.
Price is moving more forcefully than the current news tone suggests.
54/100
Weighted toneBalanced news tone
50/100
Evidence confidencebuilding confidence
100%/100
Company focus2 direct stories
94/100
Evidence agreement6/100 dispersion
News history
Tone and story flow over 21 days
23 Jul02 Aug12 Aug
Weighted toneStory volumeNeutral 50
Evidence confidence
What supports the score
Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.
Sample depth22
1.74 effective storiesSource breadth40
2 independent publishersDirect relevance100
company-specific evidence shareFreshness52
recency-weighted evidenceAgreement94
cross-story consistencySource independence42
lower publisher concentrationPrice context
Sentiment against the 26-week price path
Price is moving more forcefully than the current news tone suggests.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
Value support
News subjects
What is shaping the score
Deals and strategy671 stories · 50%
Regulatory and legal541 stories · 50%
Source mix
Where the evidence comes from
finance.yahoo.com671 stories · 50%
globenewswire.com541 stories · 50%
Recurring subjects
Subjects appearing most often
Organic Growth1Nasdaq: Adma1Inc1Earnings1Company Announcement1Class Action Lawsuit1Class Action1Aerospace Defense1Adma Biologics1Acquisition1
Earlier readings
How the score has changed
ConstructiveBalanced or withheldCautious
Source headlines
The news behind the score
Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.
#154Tone
globenewswire.comDirect company coverage
ADMA DEADLINE TOMORROW: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA
NEW YORK, Aug. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024 and March 25, 2026, both dates inclusive (the “Class Period”), of the important August 10, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased ADMA Biologics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join th
Adma BiologicsClass ActionClass Action LawsuitCompany AnnouncementIncNasdaq: Adma
- Published
- 09 Aug 2026 15:41
- Catalyst
- Regulatory and legal
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
#267Tone
finance.yahoo.comDirect company coverage
Top Stock Reports for SpaceX, Arista Networks & Boeing
Friday, August 7, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Space Exploration Technologies Corp. (SPCX), Arista Networks, Inc. (ANET) and The Boeing Co. (BA). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. You can see all of today's research reports here >>> Ahead of Wall Street The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action.
AcquisitionAerospace DefenseAIEarningsOrganic Growth
- Published
- 07 Aug 2026 21:17
- Catalyst
- Deals and strategy
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.